Back
scPharmaceuticals Vs. Aritzia Industry Stock Comparison
Sell
27
SCPH
scPharmaceuticals
Last Price:
3.32
Seasonality Move:
0.15%
Sell
40
ATZAF
Aritzia
Last Price:
32.69
Seasonality Move:
14.48%
Sell
27
scPharmaceuticals (SCPH)
is a Sell
Is scPharmaceuticals a Buy, Sell or Hold?
- The current scPharmaceuticals [SCPH] share price is $3.93. The Score for SCPH is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SCPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Aritzia (ATZAF)
is a Sell
Is Aritzia a Buy, Sell or Hold?
- The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCPH Stock Price Chart
What is scPharmaceuticals's stock price today?
-
The scPharmaceuticals share price today is $3.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCPH is experiencing slight buying pressure.
ATZAF Stock Price Chart
SCPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 37.85 | Sell |
| Chaikin Money Flow: | 93485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.06 - 4.4) | Sell |
| Bollinger Bands (100): | (4.19 - 5.05) | Sell |
ATZAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 51.58 | Buy |
| Chaikin Money Flow: | 485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.46 - 34.6) | Buy |
| Bollinger Bands (100): | (30.22 - 35.52) | Buy |
SCPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.13 | Sell |
| 20-day SMA: | 4.25 | Sell |
| 50-day SMA: | 4.54 | Sell |
| 200-day SMA: | 4.74 | Sell |
| 8-day EMA: | 4.11 | Sell |
| 20-day EMA: | 4.22 | Sell |
| 50-day EMA: | 4.41 | Sell |
| 200-day EMA: | 4.9 | Sell |
ATZAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.85 | Buy |
| 20-day SMA: | 31.82 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 29.54 | Buy |
| 8-day EMA: | 31.74 | Buy |
| 20-day EMA: | 32.3 | Buy |
| 50-day EMA: | 33.02 | Buy |
| 200-day EMA: | 30 | Buy |
scPharmaceuticals Earnings Growth & SCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Aritzia Earnings Growth & ATZAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.
scPharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aritzia Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||